DNA Discrimination: Fixing the Fears of Genetic Testing
By Olivia Nash,
Brown Political Review Magazine
| 12. 13. 2017
Genetic testing is one of the most groundbreaking technologies of the modern age. The advent of human genome sequencing has expanded medical research and enabled services such as 23andMe to offer affordable and accessible snapshots of an individual’s genetic risks. Despite the newfound ease of testing, concerns about privacy and fears of discrimination have stopped many people from getting tested or participating in medical research. The laws currently in place to guard against genomic discrimination have glaring loopholes, and out of their own financial interest, health insurance providers and employers have argued for scaling back those protections. However, genetic testing’s potentially revolutionary effects on modern medicine and individual health are too great for the fear of genetic discrimination to stand in its way. The government, rather than scaling back protections, should work to expand genetic privacy rights to encourage the testing necessary to achieve the promises of personalized medicine.
Predictive genetic testing was first offered to the population on a broad scale in the 1990s, when breast cancer was found to correlate with a mutated BRCA1/2 gene. This specific discovery...
Related Articles
By Anna Louie Sussman, The New York Times | 08.21.2026
Since in vitro fertilization was invented nearly 50 years ago, at least 10 million children who would not otherwise exist have been brought into the world. New constellations of families — older moms, same-sex parents, single dads — have flourished...
By Jenni Fink, Newsweek | 08.19.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump's latest effort to limit birthright citizenship could have consequences for the international surrogacy industry, potentially affecting thousands of intended parents from overseas who travel...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...
By Claire Robinson and Jonathan Matthews, Guest Contributors
| 08.25.2026
This is an excerpt of an article originally published on August 1, 2026 at GMWatch.
A six-year-old girl has died in a gene editing gene therapy trial in China that went wrong, the journal Science reports. Seven days after the girl's medical team infused trillions of viruses carrying the recipe for the gene editing tool – in this case a base editor – into her spinal fluid, she died of a severe immune reaction linked to the therapy.
Just...